ORIGINAL ARTICLES

Research on the application of 3D visualization-based technology to guide surgical plan for hepatic alveolar echinococcosis

  • LI Zhenwei ,
  • WANG Cheng ,
  • WANG Zhixin ,
  • LIU Jinming ,
  • ZHAO Qian ,
  • WANG Haijiu ,
  • XIE Zhi
Expand
  • Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University, Xining 810000, Qinghai, China

Received date: 2024-08-22

  Revised date: 2024-10-12

  Online published: 2025-01-14

Supported by

2023 Youth Research Fund Project of Qinghai University(2023-QYY-4);Qinghai Provincial Health Commission(Qingwei Health Office [2023] 125);Department of Science and Technology of Qinghai Province(Qingkefa Regulations [2022] 84)

Abstract

Objective Exploring the innovative application of 3D visualization technology in assisting the design of surgical treatment plans for hepatic alveolar echinococcosis (HAE). Methods Fifty HAE patients who underwent preoperative examination with 3D visualization technology at the Affiliated Hospital of Qinghai University from January 2020 to March 2023 were enrolled to participate the research. The patient’s raw data was transmitted to a human 3D visualization virtual surgical system to process 3D visual reconstruction modeling for determining the whole liver volume, planned liver resection volume, the liver volume to be reserved, and the hydatid lesion volume, thereby,the residual liver ratio was calculated, and compared with what actually seen in the operation to evaluate the application value of 3D visualization technology for HAE. Another 50 patients with HAE who did not undergo 3D visualization technology during the same period were selected as the control group. The control group received 2D enhanced CT imaging and precise liver resection. Compare the general and perioperative data between the two groups were compared and the generalized estimating equation (GEE) model was used to analyze the influencing factors on patients’ postoperative prognosis. Results There was no statistically significant difference in general information such as age, gender, body mass index (BMI), resection site, lesion diameter, excised liver volume, remaining liver volume, as well as differences in CT features and MRI imaging data between two groups of patients (P > 0.05). Compared with the control group, the study group had shorter surgical time [(228.56 ± 29.47) min], pringle method total liver block time [(26.65 ± 4.78) min], less intraoperative blood loss [(435.14 ± 98.76) ml], shorter hospital stay [(15.27 ± 2.13) days], lower hospitalization costs [(4.58 ± 0.79) yuan], and higher satisfaction with doctor-patient communication (89.65 ± 9.23) (t = 3.856, 3.561, 6.069, 3.561, 5.400, 3.812; all P < 0.05). The reconstructed 3D model can be rotated, scaled, and translated, and can also hide or render semi-transparent structures such as liver parenchyma, veins, and arteries, providing a clear and intuitive understanding of the spatial relationships between important anatomical structures and lesions in the liver. The average volume of planned liver resection predicted by 3D visualization technology is 2 154.43 ml, the average volume of reserved liver is 1 203.27 ml, and the average residual liver ratio is 41.22%. The average volume of liver resection during the operation was 2 138.75 ml, and the average volume of remaining liver was 1 193.46 ml. There was no statistically significant difference (t = 1.135, P > 0.05) between the estimated and actual liver volumes obtained through 3D visualization reconstruction. The GEE analysis results showed that the invasion of hepatic Echinococcus multilocularis edge infiltration and 3D visualization reconstruction significantly affected the prognosis of patients (χ2 = 7.890, 3.876; P < 0.05). Conclusion Three dimensional visualization technology can be used to develop a rational liver resection plan for HAE patients before surgery, improving the success rate of surgery and enhancing patients’ prognosis.

Cite this article

LI Zhenwei , WANG Cheng , WANG Zhixin , LIU Jinming , ZHAO Qian , WANG Haijiu , XIE Zhi . Research on the application of 3D visualization-based technology to guide surgical plan for hepatic alveolar echinococcosis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024 , 42(6) : 737 -743 . DOI: 10.12140/j.issn.1000-7423.2024.06.007

References

[1] Feng XB, Shang H, Lu Q, et al. Comment on “the value of hepatic vein stent placement as a bridge therapy on treating hepatic alveolar echinococcosis presenting with budd-chiari syndrome”[J]. Ann Surg, 2021, 273(4): e157-e158.
[2] Li HL, Bao HH, Fan HN, et al. CT features of hepatic alveolar echinococcosis invading venous vessels[J]. Chin High Alt Med Biol, 2021, 42(4): 269-272. (in Chinese)
  (栗海龙, 鲍海华, 樊海宁, 等. 肝泡型包虫病侵犯静脉血管的CT特征征象[J]. 中国高原医学与生物学杂志, 2021, 42(4): 269-272.)
[3] Wen J, Li Q, Zhang X, et al. Advances in the diagnosis and treatment of hepatic alveolar echinococcosis[J]. J Gastrointest Surg, 2023, 27(5): 987-996.
[4] Wang T, Liu C, Yang Y, et al. The role of immunotherapy in the management of advanced hepatic alveolar echinococcosis[J]. Clin Infect Dis, 2022, 71(10): 2431-2438.
[5] Gottstein B, Stieger B, Ackermann E, et al. Current insights into the pathogenesis and treatment of hepatic alveolar echinococcosis[J]. Parasitology, 2021, 148(S1): S11-S24.
[6] Miao J, Yang W, Chen X, et al. Vascular invasion in hepatic alveolar echinococcosis: an imaging-based review[J]. Radiology, 2023, 298(1): 156-165.
[7] Shen S. Expert consensus on diagnosis and treatment of alveolar echinococcosis (2020 edition)[J]. Chin J Bas Clin Gen Surg, 2020, 27(1): 13-17. (in Chinese)
  (沈舒. 泡型肝包虫病诊疗专家共识(2020版)[J]. 中国普外基础与临床杂志, 2020, 27(1): 13-17.)
[8] Wang C, Qiu YW, Wang WT. Application of ex vivo liver resection and autotransplantation in treating budd-chiari syndrome secondary to end-stage hepatic alveolar echinococcosis: a case series[J]. Medicine (Baltimore), 2021, 100(34): e27075.
[9] Zhang L, Wang H, Liu Y, et al. Radical hepatectomy for hepatic alveolar echinococcosis: complications and long-term outcomes[J]. Surg Endosc, 2022, 36(11): 5476-5485.
[10] Wang Y, Chen J, Ma H, et al. Advances in imaging diagnosis and interventional treatment of hepatic alveolar echinococcosis[J]. J Vasc Interv Radiol, 2021, 32(10): 1492-1502.
[11] Schantz PM, Craig PS, Ito A, et al. Echinococcosis: an emerging and re-emerging parasitic zoonosis[J]. Int J Parasitol, 2023, 53(1): 25-43.
[12] Han S, Kui Y, Xue CZ, et al. The endemic status of echinococcosis in China from 2004 to 2020[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 475-480. (in Chinese)
  (韩帅, 蒉嫣, 薛垂召, 等. 2004—2020年全国棘球蚴病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 475-480.)
[13] Yang W, Miao J, Wen J, et al. Surgical strategies for hepatic alveolar echinococcosis with major vascular involvement: areview[J]. World J Gastroenterol, 2023, 29(15): 1779-1790.
[14] Piazuelo MB, Carmena D, Moro PL, et al. Hepatic alveolar echinococcosis: a review of current management strategies[J]. J Gastrointest Surg, 2023, 27(11): 2233-2242.
[15] Gloor S, Jiang WJ, Maurer MH, et al. The trajectory of anti-recEm18 antibody levels determines follow-up after curative resection of hepatic alveolar echinococcosis[J]. HPB(Oxford), 2024, 26(2): 224-233.
[16] Zhou P, Wang Q, Zhang W, et al. Advances in radiological imaging of hepatic alveolar echinococcosis: a comprehensive review[J]. J Med Imag Radiat Oncol, 2023, 57(2): 175-184.
[17] Yan Z, Zhao BW, Lin GY, et al. Clinical application of imaging three-dimensional visualization technique in guidance of hepatectomy in patients with hepatocellular carcinoma[J]. J Pract Hepatol, 2024, 27(3): 438-441. (in Chinese)
  (闫振, 赵博文, 林国英, 等. 影像学三维可视化技术指导肝切除术治疗肝细胞癌患者临床疗效研究[J]. 实用肝脏病杂志, 2024, 27(3): 438-441.)
Outlines

/

〈 〉